The nonhomologous end-joining (NHEJ) pathway is the main mechanism repairing DNA double-strand breaks (DSBs) in human cells. This research was designed to study the association between selected variants in NHEJ members and esophageal squamous cell carcinoma (ESCC).
Methods
Two single nucleotide polymorphisms (SNPs), PRKDC (rs7003908) and X-ray repair cross complementing group 4 (XRCC4; rs1805377), were genotyped in a total of 189 patients with ESCC and 189 unrelated control individuals in a high-risk area for ESCC in North China, and the polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) method was applied.
Results
A significantly different distribution was found in the frequency of PRKDC (rs7003908) genotype between the ESCC group and controls. Individuals homozygous for the C allele had a significant (3.185-fold) increased risk of ESCC. As for XRCC4 (rs1805377) polymorphism, no difference was found in distribution between the ESCC and control groups.
Conclusions
Our results suggest that variation in DNA repair genes may be associated with risk of ESCC.
KamangarFDoresGMAndersonWFPatterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol2006;24 (14): 2137–2150
ParkinDMBrayFFerlayJPisaniPGlobal cancer statistics, 2002. CA Cancer J Clin2005;55 (2):74–108
4.
WheelerJBReedCEEpidemiology of esophageal cancer. Surg Clin North Am2012;92 (5):1077–1087
5.
LiuFGuoFZhouYThe Anyang Esophageal Cancer Cohort Study: study design, implementation of fieldwork, and use of computer-aided survey system. PLoS ONE2012;7 (2):e31602
6.
ChenWQZhangSWZouXNZhaoPCancer incidence and mortality in China, 2006. Chin J Cancer Res2011;23 (1):3–9
7.
ShimizuKHiharaJYoshidaKTogeTClinical evaluation of low-dose cisplatin and 5-fluorouracil as adjuvant chemoradiotherapy for advanced squamous cell carcinoma of the esophagus. Hiroshima J Med Sci2005;54 (3):67–71
8.
HagymásiKTulassayZ[Risk factors for esophageal cancer, and possible genetic background] [article in Hungarian]. Orv Hetil2009;150 (9):407–413
9.
MatsushimaKIsomotoHKohnoSNakaoKMicroRNAs and esophageal squamous cell carcinoma. Digestion2010;82 (3):138–144
10.
KanoMSekiNKikkawaNMiR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer2010;127 (12):2804–2814
11.
KhannaKKJacksonSPDNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet2001;27 (3):247–254
12.
LieberMRThe mechanism of human nonhomologous DNA end joining. J Biol Chem2008;283 (1):1–5
13.
MariPOFloreaBIPersengievSPDynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4. Proc Natl Acad Sci USA2006;103 (49):18597–18602
14.
DoréASFurnhamNDaviesORStructure of an Xrcc4-DNA ligase IV yeast ortholog complex reveals a novel BRCT interaction mode. DNA Repair (Amst)2006;5 (3):362–368
15.
YurchenkoVXueZSadofskyMJSUMO modification of human XRCC4 regulates its localization and function in DNA double-strand break repair. Mol Cell Biol2006;26 (5):1786–1794
16.
HartleyKOGellDSmithGCDNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell1995;82 (5): 849–856
BassoDNavagliaFFogarPDNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis. Clin Chim Acta2007;381 (1):50–55
19.
MondalPDattaSMaitiGPComprehensive SNP scan of DNA repair and DNA damage response genes reveal multiple susceptibility loci conferring risk to tobacco associated leukoplakia and oral cancer. PLoS ONE2013;8 (2):e56952
20.
McKean-CowdinRBarnholtz-SloanJInskipPDAssociations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev2009;18 (4): 1118–1126
21.
WuHCDelgado-CruzataLMachellaNWangQSantellaRMTerryMBDNA double-strand break repair genotype and phenotype and breast cancer risk within sisters from the New York site of the Breast Cancer Family Registry (BCFR). Cancer Causes Control2013;24 (12):2157–2168
22.
ZhaoPZouPZhaoLGenetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility. BMC Cancer2013;13 (1):234
23.
TsengRCHsiehFJShihCMHsuHSChenCYWangYCLung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study. Cancer2009;115 (13):2939–2948
24.
ShaoNJiangWYQiaoDAn updated meta-analysis of XRCC4 polymorphisms and cancer risk based on 31 case-control studies. Cancer Biomark2012-2013; 12 (1):37–47
25.
MargulisVLinJYangHWangWWoodCGWuXGenetic susceptibility to renal cell carcinoma: the role of DNA double-strand break repair pathway. Cancer Epidemiol Biomarkers Prev2008;17 (9):2366–2373
26.
MittalRDGangwarRMandalRKSrivastavaPAhirwarDKGene variants of XRCC4 and XRCC3 and their association with risk for urothelial bladder cancer. Mol Biol Rep2012;39 (2):1667–1675
27.
MandalRKSinghVKapoorRMittalRDDo polymorphisms in XRCC4 influence prostate cancer susceptibility in North Indian population?Biomarkers2011;16 (3):236–242
28.
ChiuCFTsaiMHTsengHCA novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol2008;44 (9): 898–902
29.
ZhouLPLuanHDongXHJinGJMaDLShangHAssociation of functional polymorphisms of the XRCC4 gene with the risk of breast cancer: a meta-analysis. Asian Pac J Cancer Prev2012;13(7):3431–3436
30.
Guirouilh-BarbatJRassEPloIBertrandPLopezBSDefects in XRCC4 and KU80 differentially affect the joining of distal nonhomologous ends. Proc Natl Acad Sci USA2007;104 (52): 20902–20907
